Evidence map›Paper›PMID 41805197›Full record

ArticleApplied and environmental microbiology2026

Optimizing antimicrobial dosing of bacterial isolates from sugar beet factories to reduce sucrose losses.

Gillian O Bruni, Evan Terrell, Tia Zimmerman, Zianab Yassin, Sanjay Joshi

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Whole genome sequence analysis of eightMicrobiology resource announcements · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gillian O BruniUSDA, Agricultural Research Service, Southern Regional Research Center, New Orleans, Louisiana, USA.ORCID 0000-0002-5856-3274
Evan TerrellUSDA, Agricultural Research Service, Southern Regional Research Center, New Orleans, Louisiana, USA.ORCID 0000-0002-1079-4110
Tia ZimmermanUSDA, Agricultural Research Service, Southern Regional Research Center, New Orleans, Louisiana, USA.
Zianab YassinUSDA, Agricultural Research Service, Southern Regional Research Center, New Orleans, Louisiana, USA.
Sanjay JoshiUSDA, Agricultural Research Service, Southern Regional Research Center, New Orleans, Louisiana, USA.ORCID 0000-0003-0971-2058

Funding

Beet Sugar Development Foundation 501USDA ARS CRIS Project 6054-30600-003-000DUSDA ARS Sustainable Sugar Beet Research Initiative
6 · The paper itself

Abstract

Bacterial growth in sugar beet factories results in sucrose losses and operational challenges during raw sugar extraction, resulting in lost revenue. Minimum inhibitory concentration (MIC) values of antimicrobial agents were measured by microdilution assay for optimized dosing to control 58 selected bacterial isolates previously obtained from sugar beet factory juices and biofilms. Hops BetaStab XL was effective against most gram-positive bacteria at 16 ppm with the exception of a few resistant IMPORTANCE: Optimal antimicrobial dosing to control key microorganisms in sugar beet factories is central to mitigating sucrose losses during sugar beet processing and preventing the additional operational challenges that often result from the production of bacterial exopolysaccharides. This study demonstrates that some antimicrobial agents effectively control key bacteria at lower concentrations while others exhibit broad variability in MIC. Additionally, elevated temperatures of factory water and juices above 50°C are another option for controlling some important microbes.

Indexed as

Anti-Bacterial AgentsBacteriaBeta vulgarisGram-Positive BacteriaSucroseMicrobial Sensitivity TestsAnti-Bacterial AgentsSucroseantimicrobialMICsucrose savingssugar beet factorytechnoeconomic analysis

Identifiers

PMID41805197
PMCPMC13101461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.